119 related articles for article (PubMed ID: 23262313)
1. Risk factors for recurrence of clostridium difficile-associated diarrhoea.
Samie AA; Traub M; Bachmann K; Kopischke K; Theilmann L
Hepatogastroenterology; 2013 Sep; 60(126):1351-4. PubMed ID: 23262313
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
Kim YG; Graham DY; Jang BI
J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
[TBL] [Abstract][Full Text] [Related]
3. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital.
Kaneria MV; Paul S
J Assoc Physicians India; 2012 Nov; 60():26-8. PubMed ID: 23767199
[TBL] [Abstract][Full Text] [Related]
5. Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficile-associated disease in nursing home patients.
Al-Tureihi FI; Hassoun A; Wolf-Klein G; Isenberg H
J Am Med Dir Assoc; 2005; 6(2):105-8. PubMed ID: 15871884
[TBL] [Abstract][Full Text] [Related]
6. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.
Pépin J; Saheb N; Coulombe MA; Alary ME; Corriveau MP; Authier S; Leblanc M; Rivard G; Bettez M; Primeau V; Nguyen M; Jacob CE; Lanthier L
Clin Infect Dis; 2005 Nov; 41(9):1254-60. PubMed ID: 16206099
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea.
Kim JW; Lee KL; Jeong JB; Kim BG; Shin S; Kim JS; Jung HC; Song IS
World J Gastroenterol; 2010 Jul; 16(28):3573-7. PubMed ID: 20653067
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.
Janarthanan S; Ditah I; Adler DG; Ehrinpreis MN
Am J Gastroenterol; 2012 Jul; 107(7):1001-10. PubMed ID: 22710578
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile-associated diarrhea and chronic renal insufficiency.
Yousuf K; Saklayen MG; Markert RJ; Barde CJ; Gopalswamy N
South Med J; 2002 Jul; 95(7):681-3. PubMed ID: 12144071
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective.
Bajaj JS; Ananthakrishnan AN; Hafeezullah M; Zadvornova Y; Dye A; McGinley EL; Saeian K; Heuman D; Sanyal AJ; Hoffmann RG
Am J Gastroenterol; 2010 Jan; 105(1):106-13. PubMed ID: 19844204
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile-associated diarrhoea in patients with human immunodeficiency virus infection: a case-control study.
Tumbarello M; Tacconelli E; Leone F; Cauda R; Ortona L
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):259-63. PubMed ID: 7743309
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial diarrhoea in adult medical patients: the role of Clostridium difficile in a North Italian acute care teaching hospital.
Sansone S; Aschbacher R; Staffler M; Bombonato M; Girardi F; Larcher C; Wiedermann CJ
J Prev Med Hyg; 2009 Jun; 50(2):117-20. PubMed ID: 20099443
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with clostridium difficile-associated disease.
Das R; Feuerstadt P; Brandt LJ
Am J Gastroenterol; 2010 Sep; 105(9):2040-9. PubMed ID: 20389295
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors and risk for Clostridium difficile associated diarrhea.
Biswal S
Biomed J; 2014; 37(4):178-83. PubMed ID: 25116712
[TBL] [Abstract][Full Text] [Related]
16. A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile.
Kazakova SV; Ware K; Baughman B; Bilukha O; Paradis A; Sears S; Thompson A; Jensen B; Wiggs L; Bessette J; Martin J; Clukey J; Gensheimer K; Killgore G; McDonald LC
Arch Intern Med; 2006 Dec 11-25; 166(22):2518-24. PubMed ID: 17159019
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease.
Dubberke ER; Reske KA; Olsen MA; McMullen KM; Mayfield JL; McDonald LC; Fraser VJ
Arch Intern Med; 2007 May; 167(10):1092-7. PubMed ID: 17533213
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
[TBL] [Abstract][Full Text] [Related]
19. Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study.
Hong SH; Lee EK; Shin JY
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):479-488. PubMed ID: 30848536
[TBL] [Abstract][Full Text] [Related]
20. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.
Arango JI; Restrepo A; Schneider DL; Callander NS; Ochoa-Bayona JL; Restrepo MI; Bradshaw P; Patterson J; Freytes CO
Bone Marrow Transplant; 2006 Mar; 37(5):517-21. PubMed ID: 16435018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
